The Clorox Company (CLX) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CLX Revenue Growth
Revenue Breakdown (FY 2025)
CLX's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
CLX Revenue Analysis (2014–2025)
As of May 8, 2026, The Clorox Company (CLX) generated trailing twelve-month (TTM) revenue of $6.76 billion, reflecting modest growth of +0.1% year-over-year. The most recent quarter (Q3 2026) recorded $1.67 billion in revenue, down 0.2% sequentially.
Looking at the longer-term picture, CLX's 5-year compound annual growth rate (CAGR) stands at +1.1%, indicating moderate growth over time. The company achieved its highest annual revenue of $7.39 billion in 2023.
Revenue diversification analysis shows CLX's business is primarily driven by Health and Wellness (38%), Household (28%), and Lifestyle (18%).
When compared to Consumer Defensive sector peers including CHD (+2.2% YoY), SPB (-6.3% YoY), and ENR (+2.7% YoY), CLX has underperformed the peer group in terms of revenue growth. Compare CLX vs CHD →
CLX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CLXCurrent | $6.8B | +0.1% | +1.1% | 16.6% | |
 CHD | $6.2B | +2.2% | +4.8% | 17.4% | |
 SPB | $2.8B | -6.3% | +1.4% | 4.4% | |
 ENR | $3.0B | +2.7% | +1.5% | 17.8% | |
 RCKY | $482M | +6.2% | +11.7% | 7.7% | |
 PG | $84.3B | +3.3% | +3.5% | 24.3% |
CLX Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $7.10B | +0.2% | $3.19B | 45.0% | $1.18B | 16.6% |
| 2024 | $7.09B | -4.0% | $3.02B | 42.6% | $916.0M | 12.9% |
| 2023 | $7.39B | +4.0% | $2.87B | 38.9% | $827.0M | 11.2% |
| 2022 | $7.11B | -3.2% | $2.49B | 35.0% | $696.0M | 9.8% |
| 2021 | $7.34B | +9.2% | $3.18B | 43.3% | $1.24B | 16.9% |
| 2020 | $6.72B | +8.2% | $3.05B | 45.4% | $1.26B | 18.8% |
| 2019 | $6.21B | +1.5% | $2.71B | 43.6% | $1.11B | 17.8% |
| 2018 | $6.12B | +2.5% | $2.66B | 43.5% | $1.13B | 18.4% |
| 2017 | $5.97B | +3.7% | $2.67B | 44.6% | $1.12B | 18.8% |
| 2016 | $5.76B | +1.9% | $2.60B | 45.2% | $1.07B | 18.5% |
Full CLX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See CLX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CLX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CLX vs WMT
Side-by-side business, growth, and profitability comparison vs Walmart Inc..
Start ComparisonCLX — Frequently Asked Questions
Quick answers to the most common questions about buying CLX stock.
Is CLX's revenue growth accelerating or slowing?
CLX revenue growth slowed to +0.1%, below the 5-year CAGR of +1.1%. TTM revenue is $6.8B. The deceleration marks a shift from historical growth rates.
What is CLX's long-term revenue growth rate?
The Clorox Company's 5-year revenue CAGR of +1.1% reflects the variable expansion pattern. Current YoY growth of +0.1% is near this long-term average.
How is CLX's revenue distributed by segment?
CLX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.